Lowest-Rated StocksLowest-RatedNYSE:BAX Baxter International (BAX) Stock Price, News & Analysis $24.26 -0.73 (-2.90%) As of 03:26 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Baxter International Stock (NYSE:BAX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Baxter International alerts:Sign Up Key Stats Today's Range$23.62▼$25.2350-Day Range$22.79▼$27.5952-Week Range$15.73▼$30.00Volume9.43 million shsAverage Volume7.82 million shsMarket Capitalization$12.55 billionP/E RatioN/ADividend Yield0.16%Price Target$21.73Consensus RatingReduce Company Overview Baxter International Inc. is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings. Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery. Its offerings are intended to support critical care, hospital operations, surgery and other areas of patient treatment. Founded in 1931, Baxter has expanded from its early focus on commercially produced intravenous solutions into a diversified healthcare company serving customers in North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. The company sells its products through direct sales organizations, distributors and other healthcare supply channels.AI Generated. May Contain Errors. Read More Baxter International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreBAX MarketRank™: 1.37445168151 of 5 starsBaxter International scored higher than 27% of companies evaluated by MarketBeat, and ranked 777th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.9 / 5Analyst RatingReduce Consensus RatingBaxter International has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no strong buy ratings, 1 buy rating, 10 hold ratings, and 3 sell ratings.Downside RiskBaxter International has a consensus price target of $21.73, representing about 9.4% downside from its current price of $23.99.Amount of Analyst CoverageBaxter International has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Baxter International's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-1.96% Earnings GrowthEarnings for Baxter International are expected to decrease by -1.96% in the coming year, from $2.04 to $2.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Baxter International is -11.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Baxter International is -11.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBaxter International has a PEG Ratio of 3.82. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBaxter International has a P/B Ratio of 2.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Baxter International's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.72% of the float of Baxter International has been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 2.98, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently increased by 4.91%, indicating that investor sentiment is decreasing. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldBaxter International has a dividend yield of 0.16%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBaxter International does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Baxter International will have a dividend payout ratio of 2.00% next year. This indicates that Baxter International will be able to sustain or increase its dividend.Read more about Baxter International's dividend. News and Social Media2.7 / 5News Sentiment0.28 News SentimentBaxter International has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Baxter International this week, compared to 10 articles on an average week.Search Interest12 people have searched for BAX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows4 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Baxter International insiders have not sold or bought any company stock.Percentage Held by Insiders0.17% of the stock of Baxter International is held by insiders.Percentage Held by Institutions90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Baxter International's insider trading history. Receive BAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BAX Stock News HeadlinesWhy Baxter (BAX) stock is down today1 hour ago | msn.comBaxter International Slides as Cautious Analyst Sentiment Weighs Ahead of Earnings4 hours ago | quiverquant.comQAI Microcap Teams With Gentex on Next-Gen Military HelmetsMorgan Stanley projects the humanoid robotics market could reach $5 trillion by 2050, with more than 1 billion robots operating worldwide. But even the most advanced machines still lack one human sense: smell. One microcap is developing an AI-powered sensor, smaller than a deck of cards, now in hands-on integration with Gentex, whose helmet systems serve U.S. forces and more than 20 NATO nations.October 20 at 1:00 AM | Capital Trends (Ad)Baxter International: The Vantive Transition Complicates Margin RecoveryOctober 13, 2026 | seekingalpha.comBaxter’s Quarterly Earnings Preview: What You Need to KnowOctober 13, 2026 | barchart.comComparing Omnicell (NASDAQ:OMCL) & Baxter International (NYSE:BAX)October 13, 2026 | americanbankingnews.comBarclays initiates coverage of Baxter International Inc. - depositary receipt at underweightOctober 11, 2026 | msn.comBaxter (BAX) Stock May Be 30% Undervalued On Cash FlowOctober 9, 2026 | finance.yahoo.comSee More Headlines BAX Stock Analysis - Frequently Asked Questions How have BAX shares performed this year? Baxter International's stock was trading at $19.12 at the beginning of 2026. Since then, BAX stock has increased by 25.5% and is now trading at $23.9940. How were Baxter International's earnings last quarter? Baxter International Inc. (NYSE:BAX) issued its earnings results on Thursday, July, 30th. The medical instruments supplier reported $0.56 EPS for the quarter, topping the consensus estimate of $0.37 by $0.19. The business's revenue was up 5.3% compared to the same quarter last year. Read the conference call transcript. Does Baxter International have any subsidiaries? Baxter International subsidiaries include these companies: Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and more. Who are Baxter International's major shareholders? Baxter International's top institutional shareholders include Lipe & Dalton (0.03%), Howard Capital Management Group LLC (0.03%), State of Alaska Department of Revenue (0.01%) and Mather Group LLC. (0.01%). View institutional ownership trends. How do I buy shares of Baxter International? Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Baxter International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Johnson & Johnson (JNJ), Pfizer (PFE), Intel (INTC), Cisco Systems (CSCO), Verizon Communications (VZ), Merck & Co., Inc. (MRK) and NVIDIA (NVDA). Company Calendar Last Earnings7/30/2026Record date for 10/1 Dividend8/28/2026Ex-Dividend for 10/1 Dividend8/28/2026Dividend Payable10/01/2026Today10/20/2026Next Earnings (Estimated)10/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 11 days, BAX's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:BAX CIK10456 Webwww.baxter.com Phone(224) 948-2000Fax224-948-1813Employees37,500Year Founded1931Price Target and Rating Average Price Target for Baxter International$21.73 High Price Target$27.00 Low Price Target$15.00 Potential Upside/Downside-10.5%Consensus RatingReduce Rating Score (0-4)1.86 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)($2.07) Trailing P/E RatioN/A Forward P/E Ratio11.90 P/E Growth3.82Net Income-$957 million Net Margins-9.27% Pretax Margin-4.21% Return on Equity16.57% Return on Assets5.24% Debt Debt-to-Equity Ratio1.39 Current Ratio1.95 Quick Ratio1.32 Sales & Book Value Annual Sales$11.24 billion Price / Sales1.12 Cash Flow$5.45 per share Price / Cash Flow4.45 Book Value$11.87 per share Price / Book2.04Miscellaneous Outstanding Shares517,000,000Free Float516,117,000Market Cap$12.55 billion OptionableOptionable Beta0.65 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NYSE:BAX) was last updated on 10/20/2026 by MarketBeat.com Staff. From Our PartnersAI Microcap Teams With Gentex on Next-Gen Military HelmetsMorgan Stanley projects the humanoid robotics market could reach $5 trillion by 2050, with more than 1 billion...Capital Trends | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | Sponsored$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredBuy These Five AI Plays Before October 20Jeff Brown, founder and CEO of Brownstone Research, says a new market cycle he calls the million dollar cycle ...Brownstone Research | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredDid you grab your copy yet?Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarte...Profits Run | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
